Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?

Ghajarzadeh, Mahsa; Bonavita, Simona

Ghajarzadeh, Mahsa; Bonavita, Simona.

Ghajarzadeh M; Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran. m.ghajarzadeh@gmail.com.
Bonavita S; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Miraglia, 2, 80138, Naples, Italy.

Neurol Sci ; 41(9): 2315-2316, 2020 09.

Article in English | MEDLINE | ID: covidwho-649603

Subject(s)

Betacoronavirus; Coronavirus Infections/epidemiology; Multiple Sclerosis/epidemiology; Pneumonia, Viral/epidemiology; Betacoronavirus/immunology; COVID-19; Coronavirus Infections/immunology; Humans; Immunologic Factors/administration & dosage; Immunologic Factors/adverse effects; Multiple Sclerosis/drug therapy; Multiple Sclerosis/immunology; Pandemics; Pneumonia, Viral/immunology; Risk Factors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Multiple Sclerosis Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Neurol Sci Journal subject: Neurology Year: 2020 Document Type: Article Affiliation country: S10072-020-04570-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google